Global Enzyme Replacement Therapy Market Projected to Reach USD 10,150.88 Million by 2026

11-Mar-2020 | Facts and Factors

Findings from Facts and Factors report “Enzyme Replacement Therapy Market By Enzyme (Imiglucerase, Agalsidase Beta, Taliglucerase, Velaglucerase Alfa, Laronidase, Alglucosidase Alfa and Others), therapeutic condition (Pompe’s disease, Gaucher’s disease, MPS, Fabry’s disease, SCID, and others), Route of administration (oral and parenteral) and End-user (hospitals, infusion centers, and others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” states that the global Enzyme Replacement Therapy market in 2019 was approximately USD 6,826.45 million. The market is expected to grow at a CAGR of 5.86% and is anticipated to reach around USD 10,150.88 million by 2026.

Enzyme Replacement Therapy Market Size

Request Sample Request Customization Buy Now

Enzymes are the proteins that conduct catalytic roles in various biochemical reactions inside the body. Lysosomal Storage Disease (LSD) is triggered by a deficit in the body's enzymes and leads to tissue inflammation. Enzyme replacement therapy for enzyme-deficient patients is the process of replacement of enzymes with artificial enzymes. The treatment is done by intravenous infusion or oral delivery of the preparation-containing enzyme. Enzyme substitution treatments are intended to increase enzyme production, but not to change the origin of the underlined disorder. Enzyme replacement therapy for disorders such as Fabry disease, Hunter syndrome, digestive diseases, and Gaucher disease, is currently available.

Browse the full “Enzyme Replacement Therapy Market By Enzyme (Imiglucerase, Agalsidase Beta, Taliglucerase, Velaglucerase Alfa, Laronidase, Alglucosidase Alfa and Others), therapeutic condition (Pompe’s disease, Gaucher’s disease, MPS, Fabry’s disease, SCID, and others), Route of administration (oral and parenteral) and End-user (hospitals, infusion centers, and others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026" report at https://www.fnfresearch.com/enzyme-replacement-therapy-market-by-enzyme-imiglucerase-agalsidase-692

Because of factors such as broader therapy supply, ease of enzyme replacement therapy acceptance guidance, and benefits such as fewer side effects, the global enzyme replacement therapy market is likely to experience high growth over the projected timeframe. Factors such as easy access to the enzyme replacement therapy and government funding for services are already expected to drive market growth. However, insurance issues in different countries and fewer therapy side effects can have a significant impact on the success of enzyme replacement therapy.

The market for Enzyme Replacement Therapy is divided into the enzyme, therapeutic condition, route of administration, end-user, and region. The enzymes segment is classified into Agalsidase Beta, Imiglucerase, Taliglucerase, Laronidase, Velaglucerase Alfa, Alglucosidase Alfa, and other enzymes. One of the important factors for the big market share of enzymes such as velaglucerasealfaand imiglucerase, is the largest occurrence of Gaucher disease. Better use of pancreatic enzymes such as amylase, lipase, and protease is typically seen in cancer patients to treat exocrine pancreatic insufficiency (EPI). The therapeutic condition segment is bifurcated into Gaucher’s disease, Pompe’s disease, SCID, MPS, Fabry’s disease, and others. Because of its large market impact, Gaucher's disease has a high incidence. Gaucher disease is a disorder that is acquired through recessive mutation. The route of administration is bifurcated into oral and parenteral. The end-user segment is segmented into hospitals, infusion centers, and others.

Geography-wise the market is segmented into the regions that comprise the current and forecast market demand for the Asia Pacific, North America, Europe, Latin America, and the Middle East & Africa with its further fragmentation into major countries. North America also dominated the market in 2019. Well-developed health-care systems and the emergence of North America's leading market players have spurred regional segment growth. Additionally, the introduction of advanced technologies and increased focus on drug development in this area is expected to drive industry growth.

Report Scope

Report Attribute

Details

Market Size in 2019

USD 6,826.45 Million

Projected Market Size in 2026

USD 10,150.88 Million

CAGR Growth Rate

5.86% CAGR

Base Year

2019

Forecast Years

2020-2026

Key Market Players

AbbVie, Actelion, Alexion, Allergan, BioMarin, Digestive Care, Horizon Pharma, Johnson & Johnson, Leadiant Biosciences, Pfizer, Recordati Rare Diseases, Sanofi and Shire amongst. , and others.

Key Segment

By Enzyme, Therapeutic Condition,Route of Administration,End-user, and Region

Major Regions Covered

North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa

Purchase Options

Request customized purchase options to meet your research needs. Explore purchase options

Some of the players included in Enzyme Replacement Therapy are AbbVie, Actelion, Alexion, Allergan, BioMarin, Digestive Care, Horizon Pharma, Johnson & Johnson, Leadiant Biosciences, Pfizer, Recordati Rare Diseases, Sanofi and Shire amongst others.

This report segments the Enzyme Replacement Therapy Market as follows:

Global Enzyme Replacement Therapy Market: Enzyme Segment Analysis

  • Imiglucerase
  • Agalsidase Beta
  • Taliglucerase
  • Velaglucerase Alfa
  • Laronidase
  • Alglucosidase Alfa
  • Others

Global Enzyme Replacement Therapy Market: Therapeutic Condition Segment Analysis

  • Gaucher Disease
  • Fabry Disease
  • Pompe Disease
  • SCID
  • MPS
  • Others

Global Enzyme Replacement Therapy Market: Route of Administration Segment Analysis

  • Oral
  • Parenteral

Global Enzyme Replacement Therapy Market: End-user Segment Analysis

  • Hospitals
  • Infusion Centers
  • Others

Global Enzyme Replacement Therapy: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:

Facts & Factors
A - 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com


Latest Market Research Reports

report img

Biliary Lithotripter Market Report 2024 – 2032

[204+ Pages Report]According to Facts Factors, the global biliary lithotripter market size in terms of revenue was valued at around USD 1,770 million in 2023 and is expected to reach a value of USD 2,630 million by 2032, growing at a CAGR of roughly 4.5% from 2024 to 2032. The global biliary lithot

Published Date : 04-Mar-2024 | | Category : Healthcare | Pages : 204 | Format : Read more

Inquiry for Buying Request Sample
report img

Arterial Stent Market Report 2024 – 2032

[245+ Pages Report] According to Facts Factors, the global arterial stent market size in terms of revenue was valued at around USD 17.02 billion in 2023 and is expected to reach a value of USD 41.24 billion by 2032, growing at a CAGR of roughly 10.33% from 2024 to 2032. The global arterial stent ma

Published Date : 01-Mar-2024 | | Category : Healthcare | Pages : 245 | Format : Read more

Inquiry for Buying Request Sample
report img

Autosamplers Market Report 2024 – 2032

[250+ Pages Report] According to Facts Factors, the global autosamplers market size in terms of revenue was valued at around USD 1,660.23 million in 2023 and is expected to reach a value of USD 3,112.02 million by 2032, growing at a CAGR of roughly 7.23% from 2024 to 2032. The global autosamplers m

Published Date : 01-Mar-2024 | | Category : Healthcare | Pages : 250 | Format : Read more

Inquiry for Buying Request Sample
report img

Vision Sensor Market Report 2024 – 2032

[229+ Pages Report] According to Facts and Factors,The global vision sensor market size was valued at USD 4.51 billion in 2023 and is predicted to surpass USD 10.05 billion by the end of 2032. The vision sensor industry is expected to grow by a CAGR of 9.31% between 2024 and 2032. Vision Sensor Mar

Published Date : 29-Feb-2024 | | Category : Technology & Media | Pages : 229 | Format : Read more

Inquiry for Buying Request Sample
report img

Insurance Analytics Market Report , 2024 to 2032

[228+ Pages Report] According to Facts and Factors,the global insurance analytics market size was valued at USD 13.14 billion in 2023 and is predicted to surpass USD 43.80 billion by the end of 2032. The insurance analytics industry is expected to grow by a CAGR of 14.31% between 2024 and 2032. Ins

Published Date : 28-Feb-2024 | | Category : Public Sector | Pages : 228 | Format : Read more

Inquiry for Buying Request Sample

Why FnF Market Research?

1 Inflallible Methodology

to ensure high-level data integrity, accurate analysis, and impeccable forecasts

2 Analyst Support

for complete satisfaction

3 Customization

on-demand customization of scope of the report to exactly meet your needs

4 Targeted Market View

Targeted market view to provide pertinent information and save time of readers

5 Agile Approach

A faster and efficient way to cater to the needs with continuous iteration